The aim of this study is to search for the origin of the term "ligament' in the face, present its status, and suggest a principle to rectify the use of unclear terminology.The structure that connects the zygoma to the skin was first presented by McGregor (1959). Kaye (1981), in describing his "extended facelift," wrote that the adherent area of the cheek over the malar eminence (McGregor's patch) usually requires sharp dissection. Bosse (1987) reported that the zygomatic ligament is quite solidly bound to the malar eminence and usually requires sharp dissection to release it. The origin of the term was introduced later by Furnas, who stated that when Preddy, a medical artist, prepared drawings for McGregor's slide presentations, she insisted on naming it "McGregor's patch." With the idea that "perhaps" the "retaining ligaments" of the face share a teleologic kinship with Cleland's ligaments or Grayson's ligaments of the hands, Furnas (1989) observed the structure that anchors the skin of the cheek to the inferior border of the zygoma just posterior to the origin of the zygomaticus minor muscle, and named it "the zygomatic ligaments." Subsequently, numerous articles have been published using different terminologies that cause confusion.To rectify the present confusing terminology of the ligament of face, the histologically proven structures should be designated by one term only following the Nomina Anatomica principles.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SCS.0000000000004416 | DOI Listing |
Alzheimers Dement
December 2024
Unitiy Hospital, Rochester, NY, USA.
Background: Psychotropic drug prescriptions are commonly used to manage behavioral and psychological symptoms of dementia in elderly patients in long-term care facilities. The prevalence of psychotropic drug use in this population raises concerns due to potential side effects, polypharmacy and quality of life of the patients.
Aim: To assess the trends in psychotropic drug prescriptions for elderly patients with dementia following the continuous implementation of multimodal comprehensive care communication skills training for staff in a long-term care hospital.
Diabetes Obes Metab
January 2025
Unit of Pediatrics Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Aim: To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile.
Materials And Methods: Double-blind, randomized, placebo-controlled study conducted in North Italy. Fifty-six patients (10-18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo-inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant-based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant-based origin (1000 mg).
J Med Life
November 2024
Department of Radiology and Imagistic Medicine 1, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
The gene (OMIM: 608271) encodes the Microtubule-Actin Cross-Linking Factor 1 protein. Existing medical research shows that genetic mutations in the gene have been associated with neurodevelopmental and neurodegenerative disorders, with variants of unknown significance also linked to autism spectrum disorder (ASD). However, the number of reported autism disorder or epilepsy cases associated with mutations remains limited.
View Article and Find Full Text PDFMediastinum
November 2024
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Background: Thymoma is a rare mediastinal neoplasm originating from thymic epithelial cells, often associated with paraneoplastic syndromes. These syndromes can manifest as a range of autoimmune disorders, including myasthenia gravis, pure red cell aplasia, and aplastic anemia. Clinical trials involving the use of immune checkpoint inhibitors (ICIs) in thymoma have been complicated by a high incidence of immune-related adverse effects (irAEs).
View Article and Find Full Text PDFSurg Neurol Int
December 2024
Department of Neurosurgery, Padilla Hospital of Tucuman, San Miguel de Tucuman, Argentina.
Background: Petroclival meningiomas are still a neurosurgical challenge due to their proximity to cranial nerves and cerebral vasculature along the surgical corridor. The usual extension of large petroclival meningiomas is along the posterior fossa, frequently compromising and displacing adjunct cranial nerves such as the sixth and seventh-eight cranial nerve complex with brainstem compression, causing progressive neurological deficit and severe headache. The goal of sizeable petroclival meningioma surgery treatment is a maximal resection with preservation of neurological function.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!